ASX:4DXHealthcare Services
Is 4DMedical’s (ASX:4DX) New CFO Appointment Quietly Reframing Its U.S. Commercial Ambitions?
On January 2, 2026, 4DMedical appointed long‑serving non‑executive director and early investor Julian Sutton as Executive Director and Chief Financial Officer for a three‑year term, formalising his long‑running involvement in capital strategy and commercial operations.
The move aligns financial leadership with deep internal knowledge at a time when CT:VQ™ is FDA‑cleared, deployed in leading U.S. centres, and supported by a global distribution agreement with Philips.
We’ll now examine how...